Anterix Analyst Price Targets - Benzinga

Anterix Inc

ATEXNASDAQ

Trade with Public

Trade with Public

$79.44

1.572.02%

Dern. MÀJ: Oct 20, 4:00 PM

$79.44

1.572.02%

Aperçu Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Anterix Analyst Price Targets - Benzinga

Anterix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anterix (ATEX).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingOverweight# Analysts2Avg. Consensus PT$82Upside to Avg. PT+2.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 13, 2026	JP Morgan	Sebastiano Petti	PT Cut	Overweight	$133→$130
Jul 20, 2026	JP Morgan	Sebastiano Petti	PT Raise	Overweight	$50→$133
Jun 4, 2026	B. Riley Securities	Mike Crawford	Downgrade	Buy→Neutral	$44→$69
Oct 17, 2025	JP Morgan	Sebastiano Petti	PT Cut	Overweight	$67→$50
Feb 13, 2025	JP Morgan	Jerome Darling	PT Raise	Overweight	$61→$67
Aug 8, 2024	JP Morgan	Philip Cusick	PT Raise	Overweight	$60→$61
Feb 16, 2024	B. Riley Securities	Mike Crawford	Maintained	Buy	$75

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Anterix, Lowers Price Target to $130

JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and lowers the price target from $133 to $130.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $133

JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.

Benzinga Newsdesk

PRO
B. Riley Securities Downgrades Anterix to Neutral, Raises Price Target to $69

B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.

Benzinga Newsdesk

PRO
Watching Anterix; Shares See Volume To The Upside, Hearing Zacks Home Run Investor Newsletter Mentions Stock As A Buy

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $67

JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anterix, Raises Price Target to $61

JP Morgan analyst Philip Cusick maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $60 to $61.

Benzinga Newsdesk